Regulating glucagon secretion: somatostatin in the spotlight
A randomized, double-blind, placebo-controlled trial found that mulberry extract decreased total glucose and insulin rises without significant side effects
Summary of timing variables to experiment with Here is a quick reference table for the variables you can adjust: What the clinical trial data tells us about timing The phase 2 retatrutide trial published in the New England Journal of Medicine enrolled 338 participants and tested doses ranging from 1 mg to 12 mg over 48 weeks
our model assumes a 25% annual attrition rate, and that lapsed patients regain about two-thirds of the weight lost. Household impacts While survey data focuses on people taking obesity medicines, we could see a greater change to food consumption if the behavioral changes affect people in AOM patients households or social circles, speculates Morgan Stanley
Clinical Results and Safety Phase 2 clinical trials have reported encouraging weight loss outcomes, with participants receiving the highest doses achieving an average body weight reduction of approximately 24% over 48 weeks
Ophthalmology Sci
